Clinical Trial Update: ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion [Phase 4]

View source ↗

Summary

A Phase 4 trial titled 'ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion' was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Intermittent Claudication

Snippet

Sponsor: University of California, San Diego | Conditions: Arterial Occlusive Disease, Intermittent Claudication | Phase 4 | Status: WITHDRAWN